Valuation: Steris PLC

Market Cap 22.56B 20.08B 18.42B 16.74B 31.51B 2,135B 32.21B 219B 88.11B 1,128B 84.66B 82.85B 3,573B P/E 2027 *
27.4x
P/E 2028 * 24.4x
Enterprise Value 23.95B 21.32B 19.56B 17.77B 33.46B 2,266B 34.2B 233B 93.55B 1,198B 89.89B 87.96B 3,793B EV / Sales 2027 *
3.75x
EV / Sales 2028 * 3.45x
Free-Float
99.7%
Yield 2027 *
1.07%
Yield 2028 * 1.16%
Manager TitleAgeSince
Chief Executive Officer 53 2021-07-28
Director of Finance/CFO 59 2025-08-17
Compliance Officer - 2019-07-31
Director TitleAgeSince
Director/Board Member 73 2005-02-28
Director/Board Member 54 2018-04-30
Chairman 67 2018-07-27
Change 5-day change 1-year change 3-year change Capi.($)
+0.96%+3.19% - - 22.56B
+5.59%+12.04%-6.73%+20.52% 189B
+6.15%+11.72%+16.36%+44.65% 121B
+9.37%+12.68%-5.17%+22.96% 118B
+2.63%+4.02%-40.35%+8.53% 94.78B
+3.96%+8.80%+3.83%+81.38% 64.98B
+5.56%+7.26%+17.99%-19.20% 53.98B
+3.94%+24.46%-3.37%+62.72% 52.94B
-1.45%-7.41%-2.67%+59.52% 52.3B
+5.75%+9.90%+7.33%-5.58% 35.25B
Average +3.67%+4.25%-1.42%+30.61% 86.98B
Weighted average by Cap. +3.70%+4.39%-3.28%+29.77%

Financials

2027 *2028 *
Net sales 6.38B 5.68B 5.21B 4.73B 8.91B 604B 9.11B 62.01B 24.92B 319B 23.94B 23.43B 1,010B 6.81B 6.06B 5.56B 5.05B 9.51B 644B 9.72B 66.18B 26.59B 341B 25.55B 25.01B 1,078B
Net income 889M 791M 726M 660M 1.24B 84.12B 1.27B 8.64B 3.47B 44.47B 3.34B 3.26B 141B 990M 881M 808M 734M 1.38B 93.65B 1.41B 9.62B 3.87B 49.51B 3.71B 3.63B 157B
Net Debt 1.39B 1.24B 1.14B 1.03B 1.95B 132B 1.99B 13.55B 5.44B 69.72B 5.23B 5.12B 221B 960M 855M 784M 712M 1.34B 90.85B 1.37B 9.33B 3.75B 48.03B 3.6B 3.53B 152B
Logo Steris PLC
STERIS plc is one of the world's leading suppliers of sterilisation solutions and medical equipment. Net sales by business area break down as follows: - sale of sterilisation solutions and surgical equipment (70.9%): primarily cleaning products, accessories for gastrointestinal surgery, washers, sterilisers, surgical tables, lighting systems, etc. In addition, the group offers equipment repair and maintenance services; - development of sterilisation solutions (19.2%): sterilisation services, laboratory testing, and product and packaging testing for manufacturers of medical devices and pharmaceutical products; - sales of consumables and equipment (9.9%): for biopharmaceutical companies and manufacturers of medical devices. Net sales by source of income break down into sales of equipment (51.5%) and services (48.5%). Net sales are distributed geographically as follows: Ireland (1.8%), the United States (73%) and other (25.2%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Steris PLC